If the state were to change its course, aid in dying would become more accessible to millions of Americans.
NYT > Health
Related Posts
Patients Hate ‘Forever’ Drugs. Are Ozempic and Wegovy Different?
The new obesity drugs might be an exception to a chronic, deadly problem: the failure to stick with medication. NYT > Health
Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.” NYT > Health
Opioid Settlement Hinders Patients’ Access to ADHD Medication and Other Drugs
An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain. NYT > Health